Sumitomo Seika Chemicals Co., Ltd.

As of March 31, 2026, Sumitomo Seika Chemicals Co., Ltd. carries a market capitalization of 76.46B, placing it among publicly traded companies globally. Its enterprise value stands at 76.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sumitomo Seika Chemicals Co., Ltd.'s next confirmed earnings release is scheduled for November 11, 2026.

As of March 31, 2026, Sumitomo Seika Chemicals Co., Ltd. has 64.68M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Sumitomo Seika Chemicals Co., Ltd. maintains a current ratio of 2.51, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Sumitomo Seika Chemicals Co., Ltd.'s stock has gained approximately 50.62% over the past 52 weeks. The 50-day moving average sits at 1,504.72, while the 200-day moving average is 1,309.55.

As of March 31, 2026, Sumitomo Seika Chemicals Co., Ltd. holds 18.22B in cash and equivalents against 17.93B in total debt, resulting in a net debt position of -739.00M. Total book value stands at 103.62B, with working capital of 49.56B providing operational flexibility.

Sumitomo Seika Chemicals Co., Ltd.'s most recent stock split took place on March 30, 2026 with a 1:5 split ratio.